Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea
The objective of this PMS is to gain information about safety and efficacy in real practice as a regulatory commitment required by KFDA (Korea Food and drug administration)
- Signed and dated informed consent - Women after menarche and before menopause - Women requesting contraception or Women diagnosed by a physician as having HMB due to non-organic cause who are also requesting contraception - Women who are prescribed Qlaira® for the first time, during the study period
- All contraindications according to the local marketing authorization have to be considered.
Many Locations, South Korea
E-mail: [email protected]
Qlaira® Regulatory Post Marketing Surveillance Study in Korea